Loblaw Reports Third Quarter Retail Sales Growth of 3.6% and Adjusted Diluted Net Earnings Per Common Share Growth of 8.8%

Releases

November 19, 2026

Loblaw Reports Third Quarter Retail Sales Growth of 3.6% and Adjusted Diluted Net Earnings Per Common Share Growth of 8.8%

Releases

November 19, 2026

Loblaw Reports Third Quarter Retail Sales Growth of 3.6% and Adjusted Diluted Net Earnings Per Common Share Growth of 8.8%

BRAMPTON, ONTARIO, November 19, 2026 Loblaw Companies Limited (TSX: L) (“Loblaw” or the “Company”) announced today its unaudited financial results for the third quarter ended October 10, 2026(¹).

Loblaw delivered solid operational and financial results in the third quarter of 2026, with Retail sales growth of 3.6% and adjusted diluted net earnings per common share growth of 8.8%. Following the completion of the sale of PC Financial on July 1, 2026, the Company’s results reflect its Retail operations and the recognition of its proportionate share of EQB Inc. (“EQB”)’s net income. Due to the timing of the transaction close and differences in reporting periods, the Company’s third quarter results included only one month of earnings contribution from EQB. Across its Retail business, Loblaw maintained its focus on everyday value offerings, personalized PC OptimumTM loyalty rewards and impactful promotions across its nationwide network of stores and digital platforms. In Drug Retail, sales grew 5.7%, reflecting strong performance in pharmacy and healthcare services, led by specialty and chronic prescriptions. Front store sales growth was driven by strength in beauty and over-the-counter products. More than 4 million questions have been asked since the launch of the Company’s AI powered PC ChatTM across the country, helping Canadians find trusted information and better manage their healthcare. In Food Retail, sales grew 2.8%, supported by new store openings. The Company’s internal food inflation was in line with food CPI, and e-commerce sales grew 16.9% in the quarter. Loblaw continued its strategic network expansion, opening 18 stores across its network, including 9 hard discount stores and 7 drug stores, bringing convenient access to nutritious food and essential healthcare services to more communities.

“Loblaw's third quarter results reflect our continued focus on delivering the value, quality, service and convenience our customers expect across our growing retail network and digital platforms,” said Per Bank, President and Chief Executive Officer, Loblaw Companies Limited. “Our investments in core retail and the strength of our assets position us to meet the evolving needs of Canadians while creating opportunities for long-term profitable growth.”

2026 THIRD QUARTER HIGHLIGHTS

  • Retail sales were $19,857 million, an increase of $697 million, or 3.6%.

    • Food Retail (Loblaw) same-store sales increased by 0.6% (2025 – 2.0%).

    • Drug Retail (Shoppers Drug Mart) same-store sales increased by 4.8% (2025 – 4.0%), with pharmacy and healthcare services same-store sales growth of 7.6% and front store same-store sales growth of 1.6%.

    • E-commerce sales increased by 16.9%.

  • Retail gross profit percentage(²) was 31.3%, an increase of 20 basis points.

  • Retail operating income was $1,408 million, an increase of 9.7%.

  • Adjusted EBITDA(²) was $2,250 million, an increase of 6.9%.

    • Retail selling, general and administrative expenses (“SG&A”) as a percentage of sales was 20.0%, a decrease of 20 basis points.

  • Net earnings(³) of the Company were $1,193 million, an increase of 50.3%. Diluted net earnings per common share were $1.03, an increase of 56.1%. Net earnings included the gain on sale of PC Financial, net of transaction costs, of $401 million, presented within discontinued operations.

  • Adjusted net earnings(²),(³) of the Company were $857 million, an increase of 4.8%. Adjusted diluted net earnings per common share(²) were $0.74, an increase of 8.8%.

    • Adjusted diluted net earnings per common share(²) growth of 8.8% included $9 million of the Company’s proportionate share of EQB’s net income, reflecting one month of earnings, and excluded two months, as a result of timing of the sale of PC Financial on July 1, 2026 and EQB’s quarter-end date of July 31, 2026.

  • Adjusted diluted net earnings per common share(²) from continuing operations were $0.74, an increase of 15.6%.

  • Free cash flow(²) from Retail was $324 million, a decrease of $23 million. Gross capital investments were $897 million.

  • Repurchased and cancelled 8.3 million common shares at a cost of $524 million.

¹This News Release contains forward-looking information. See “Forward-Looking Statements” section of this News Release and the Company’s 2026 Third Quarter Report to Shareholders for a discussion of material factors that could cause actual results to differ materially from the forecasts and projections herein and of the material factors and assumptions that were used when making these statements. This News Release should be read in conjunction with Loblaw Companies Limited’s filings with securities regulators made from time to time, all of which can be found at sedarplus.ca and at loblaw.ca.

²See “Non-GAAP and Other Financial Measures” section of this News Release, which includes the reconciliation of such non-GAAP and other financial measures to the most directly comparable GAAP measures.

³Net earnings represents net earnings available to common shareholders.

⁴Certain figures have been restated due to the non-GAAP financial measures adjusting item change. See Section 11 “Non-GAAP and Other Financial Measures” of the Company’s 2026 Third Quarter Report to Shareholders.

Have investor questions?

Contact us

investor@loblaw.ca(Open in a new tab)

For information regarding share transfer, address changes, dividends, lost share certificates or tax forms, please contact Loblaw’s Registrar and Transfer Agent:

Computershare Investor Services Inc.

100 University Avenue Toronto, Canada M5J 2Y1 1-800-564-6253

Toll Free Tel 1-800-564-6253 (Canada and US) Tel 514-982-7555 (International direct dial) Fax 416-263-9394 Toll Free Fax 1-888-453-0330